Sei Investments CO Ionis Pharmaceuticals Inc Transaction History

Sei Investments CO

$75.3 Billion
Q4 2024

A detailed history of Sei Investments CO transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Sei Investments CO holds 70,091 shares of IONS stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,091

Previous 189,837 63.08%

Holding current value

$2.31 Million

Previous $7.6 Million 67.78%

% of portfolio

0.0%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$33.73 - $40.36 $4.04 Million - $4.83 Million	-119,746 Reduced 63.08%	70,091 $2.45 Million
Q3 2024 Nov 12, 2024	BUY	$40.06 - $51.86 $2.3 Million - $2.98 Million	57,526 Added 43.48%	189,837 $7.6 Million
Q2 2024 Aug 13, 2024	BUY	$36.45 - $47.7 $1.91 Million - $2.5 Million	52,424 Added 65.62%	132,311 $6.31 Million
Q1 2024 May 07, 2024	BUY	$42.03 - $53.55 $408,279 - $520,184	9,714 Added 13.84%	79,887 $3.46 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $236,996 - $282,003	5,462 Added 8.44%	70,173 $3.55 Million
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $1.9 Million - $2.33 Million	49,401 Added 322.67%	64,711 $2.94 Million
Q2 2023 Aug 11, 2023	SELL	$34.73 - $43.33 $1.06 Million - $1.33 Million	-30,614 Reduced 66.66%	15,310 $628,000
Q1 2023 May 12, 2023	SELL	$33.58 - $41.2 $570 - $700	-17 Reduced 0.04%	45,924 $1.64 Million
Q4 2022 Feb 10, 2023	BUY	$37.12 - $46.52 $995,261 - $1.25 Million	26,812 Added 140.16%	45,941 $1.74 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $310,699 - $413,755	8,503 Added 80.02%	19,129 $845,000
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $12,430 - $16,856	-392 Reduced 3.56%	10,626 $392,000
Q1 2022 May 13, 2022	SELL	$29.88 - $37.04 $5,258 - $6,519	-176 Reduced 1.57%	11,018 $407,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $70,760 - $96,981	-2,763 Reduced 19.8%	11,194 $339,000
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $3,186 - $3,852	-95 Reduced 0.68%	13,957 $401,000
Q2 2021 Aug 06, 2021	SELL	$34.54 - $47.25 $463,181 - $633,622	-13,410 Reduced 48.83%	14,052 $492,000
Q1 2021 May 12, 2021	BUY	$42.51 - $63.78 $34,475 - $51,725	811 Added 3.04%	27,462 $1.38 Million
Q4 2020 Feb 08, 2021	SELL	$45.3 - $60.27 $2.65 Million - $3.52 Million	-58,480 Reduced 68.69%	26,651 $1.46 Million
Q3 2020 Dec 04, 2020	SELL	$47.45 - $62.95 $12,858 - $17,059	-271 Reduced 0.32%	85,131 $4.01 Million
Q3 2020 Nov 06, 2020	SELL	$47.45 - $62.95 $410,395 - $544,454	-8,649 Reduced 9.2%	85,402 $4.03 Million
Q2 2020 Aug 17, 2020	SELL	$46.85 - $61.05 $347,627 - $452,991	-7,420 Reduced 7.31%	94,051 $5.53 Million
Q2 2020 Aug 11, 2020	BUY	$46.85 - $61.05 $514,787 - $670,817	10,988 Added 12.14%	101,471 $6.11 Million
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $341,702 - $520,767	-8,214 Reduced 8.32%	90,483 $4.28 Million
Q4 2019 Feb 06, 2020	BUY	$53.85 - $65.27 $1.43 Million - $1.73 Million	26,555 Added 36.81%	98,697 $5.96 Million
Q3 2019 Nov 12, 2019	BUY	$59.06 - $72.15 $183,145 - $223,737	3,101 Added 4.49%	72,142 $4.32 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $111,265 - $154,362	1,792 Added 2.66%	69,041 $4.44 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $675,894 - $1.04 Million	12,772 Added 23.44%	67,249 $5.46 Million
Q3 2018 Nov 08, 2018	SELL	$42.88 - $53.7 $1.92 Million - $2.4 Million	-44,728 Reduced 45.09%	54,477 $2.81 Million
Q2 2018 Aug 03, 2018	BUY	$40.53 - $50.7 $955,373 - $1.2 Million	23,572 Added 31.17%	99,205 $4.13 Million
Q1 2018 May 11, 2018	BUY	$44.08 - $55.05 $848,011 - $1.06 Million	19,238 Added 34.11%	75,633 $3.33 Million
Q4 2017 Feb 08, 2018	BUY	$50.3 - $64.39 $27,463 - $35,156	546 Added 0.98%	56,395 $2.84 Million
Q3 2017 Nov 06, 2017	BUY	$45.56 - $59.57 $2.54 Million - $3.33 Million	55,849	55,849 $2.83 Million

Others Institutions Holding IONS

# of Institutions

412

Shares Held

140M

Call Options Held

829K

Put Options Held

789K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.67B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Ionis Pharmaceuticals Inc Transaction History